적혈구증가증의 감별진단

A Diagnostic Roadmap for Polycythemia

초록

Polycythemia could be defined as an elevation in hemoglobin or hematocrit levels above normal. To figure out what induces polycythemia is very important since the causes of polycythemia are very variable and the approaches for the treatments are basically different. Polycythemia can be primary or secondary in origin. The secondary causes are all associated with increase in erythropoietin (EPO) levels. If serum EPO levels are elevated, one try to differentiate whether the elevation is a physiologic response to hypoxemia or is related to autonomous production. Patients with low arterial O2 saturation (< 92%) should be further evaluated for the presence of heart or lung disease. Patients without hypoxemia who are smokers may have elevated EPO levels because of CO displacement of O2. If carboxyhemoglobin levels are elevated, the diagnosis is smoker’s polycythemia. Patients without hypoxemia who do not smoke, either could be diagnosed as high oxygen affinity hemoglobinopathy or have EPO producing tumors. If EPO levels are low, the patients most likely have polycythemia vera which has almost JAK2 mutation.

키워드

Polycythemia; Hypoxia; Erythropoietin; JAK2V617F
제목
적혈구증가증의 감별진단
제목 (타언어)
A Diagnostic Roadmap for Polycythemia
저자
성화정
DOI
10.3904/kjm.2020.95.1.27
발행일
2020-02
저널명
대한내과학회지
권
95
호
1
페이지
27 ~ 30